Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
2,712
-228
-8% -$18.4K 0.01% 586
2026
Q1
$208K Buy
2,940
+376
+15% +$28.1K 0.01% 588
2025
Q4
$202K Buy
+2,564
New +$203K 0.01% 552
2022
Q3
Sell
-16,978
Closed -$1.07M 226
2022
Q2
$1.07M Buy
16,978
+603
+4% +$39.9K 0.28% 47
2022
Q1
$1.15M Buy
16,375
+2,909
+22% +$197K 0.25% 65
2021
Q4
$841K Buy
13,466
+426
+3% +$26.7K 0.18% 88
2021
Q3
$805K Buy
13,040
+247
+2% +$14.9K 0.16% 107
2021
Q2
$766K Buy
12,793
+1,188
+10% +$75.3K 0.18% 80
2021
Q1
$705K Buy
11,605
+281
+2% +$15.5K 0.19% 81
2020
Q4
$532K Sell
11,324
-1,019
-8% -$44.2K 0.17% 96
2020
Q3
$459K Buy
12,343
+584
+5% +$22.2K 0.18% 87
2020
Q2
$429K Buy
+11,759
New +$409K 0.2% 77

Other funds holding MET

Certuity's MET Position: Q2 2026 in Review

Certuity reduced its MetLife (MET) stake by 7.8% in Q2 2026, selling an estimated $18.4K and leaving 2,712 shares worth $229K. The position accounts for 0.01% of the portfolio, ranked #586.

Certuity first reported a position in MET in Q2 2020 and has held it in 12 quarters since. The position peaked at $1.15M in Q1 2022. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Certuity held 2,712 shares of MetLife worth $229K as of Q2 2026.
  • Certuity sold 228 MetLife shares in Q2 2026, an estimated $18.4K.
  • MetLife made up 0.01% of Certuity's portfolio in Q2 2026, its #586 holding.
  • Certuity first reported a position in MetLife in Q2 2020 and has held it in 12 quarters since.
  • Certuity's MetLife position peaked at $1.15M in Q1 2022.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Certuity's 13F filing for Q2 2026, filed 28 Jul 2026.